Podcasts about Robotti

In this episode of EisnerAmper's Engaging Alternative Spotlight, Elana Margulies-Snyderman, Director, Publications, EisnerAmper, speaks with Bob Robotti, Founder & CIO of Robotti & Co. and Theo van der Meer, Senior Associate-Asset Management at Robotti & Co. They share their outlook for value investing including the greatest opportunities, challenges and more. They also share their outlook on asset allocation and what investors might be missing.

Welcome to this special episode of TVP, where Juan and Andrew Williams will take you behind the scenes of the New York Value Conference. Recorded live on the conference floor, just as we've done in the past at the London Value Conference in the London Quality and Growth Conference. We are fortunate to line up an incredible slate of guests ranging from those who presented on stage to attendees at the conference itself.   In today's episode, we were joined by some stalwarts and rising stars in the value investing world, including David Salem from Hedgeye Risk Management, returning guest Django Davidson from Hosking Partners, David Samra from Artisan Partners and David Iben from Kopernik Global Investors. You also hear from Jonathan Boyar of Boyar Value Group, Anand Vasagiri from Artisan Partners, C.T. Fitzpatrick from Vulcan Value Partners and two more returning guests, Jim Osman from the Edge Group and Andrew McDermott from the Mission Value Partners. We also sat with Samantha McLemore from Patient Capital Management, Bob Robotti from Robotti & Company. And finally Richard Pzena from Pzena Investment Management - rounding out an episode packed with insights from some of the most respected names in the value investing space. And of course, a huge thank you to Robert Hunter for inviting us all the way to New York and making this possible. NEW EPISODES: We release main series episodes every two weeks on Mondays. You can subscribe via Podbean or use this feed URL (https://tvpschroders.podbean.com/feed.xml) in Apple Podcasts, Spotify, Google Podcasts and other podcast players. GET IN TOUCH: Send us a tweet: @TheValueTeam  Important information. This podcast is for investment professionals only. Marketing material for Financial Professionals and Professional Clients only.  The material is not intended to provide, and should not be relied on for, accounting, legal or tax advice, or investment recommendations. Reliance should not be placed on any views or information in the material when taking individual investment and/or strategic decisions.   Past Performance is not a guide to future performance and may not be repeated.  Diversification cannot ensure profits or protect against loss of principal.  The value of investments and the income from them may go down as well as up and investors may not get back the amounts originally invested.   Exchange rate changes may cause the value of investments to fall as well as rise.  Investing in emerging markets and securities with limited liquidity can expose investors to greater risk.  Private assets investments are only available to Qualified Investors, who are sophisticated enough to understand the risk associated with these investments.  This material may contain “forward-looking” information, such as forecasts or projections. Please note that any such information is not a guarantee of any future performance and there is no assurance that any forecast or projection will be realised.   Reliance should not be placed on any views or information in the material when taking individual investment and/or strategic decisions. The views and opinions contained herein are those of the individuals to whom they are attributed and may not necessarily represent views expressed or reflected in other Schroders communications, strategies or funds.  Any reference to regions/ countries/ sectors/ stocks/ securities is for illustrative purposes only and not a recommendation to buy or sell any financial instruments or adopt a specific investment strategy.   Any data has been sourced by us and is provided without any warranties of any kind. It should be independently verified before further publication or use. Third party data is owned or licenced by the data provider and may not be reproduced, extracted or used for any other purpose without the data provider's consent. Neither we, nor the data provider, will have any liability in connection with the third party data.

Tällä kertaa arvostelussa Dreamworksin uusin animaatio leffa Villi robotti, joka tuli käytyä katsomassa lasten kanssa.  Näin ensimmäisen trailerin ja se vaikutti varsin hyvältä. Sen lisäksi kehut ympäri maailmaa, lisäsi vain kiinnostusta. Joten olihan tämä pakko käydä katsomassa.  Mutta millaisen leffan Dreamworks on onnistunut tällä kertaa tekemään? Ja onko leffa hyvä? Näihin kysymyksiin haetaan vastausta arvostelusta.  Oletko jo nähnyt tämän? Mitä mieltä? Mikä on sinun suosikki Dreamworks leffa? 

Ancora fino al 22 ottobre sarà possibile recarsi alla mostra "Fuori-Luogo" in Biblioteca Francesca Calvo in Alessandria. La mostra raccoglie le impressioni che si hanno arrivando in una città, in questo caso Alessandria. Ne parliamo con il fotografo Daniele Robotti, ideatore del progetto.

Pieni robotti-imuri on eksynyt aivan väärille teille helsinkiläisessä naapurustossa, mikä on aiheuttanut keskustelua somessa.

Olemme PBC….P…B…C Pelikerho on taas kokoontunut paikalla ja tällä kertaa mitä kutkuttavimman tapauksen kanssa kun luvassa on Sonyn 3D-tasoloikinta eksklusiivi Astro Bot. Mutta ei jakso pelkkää Astroilua ollut, vaan oli siinä paljon muutakin. Neljän hengen cast on jo itsessäänkin nykyisin … Lue loppuun →

Suzanne Robotti is an FDA Consumer Representative, Drug Side Effects Expert, DES Daughter, and founder of MedShadow Foundation, a nonprofit organization which encourages people to think for themselves, not to believe everything you read online, do your own diligent research, and balance the benefits with the risks of medications. She launched MedShadow Foundation in 2013 because she herself was harmed by a medication called DES that was given to her mother when she was pregnant with Su. At the young age of 13, Su learned that she would never be able to have children because of the harmful side effects of DES. Generations later, DES has been found to cause rare cancers, autoimmune diseases, and infertility. In 2017 Su was appointed to the FDA Advisory Committee on Drug Safety and Risk Management as the lone consumer representative on a panel of doctors and pharmacists. She considers it a privilege to have a seat at the table when the FDA is deciding if a drug is safe and effective enough to use.   Su shares her own personal story of dealing with the harmful side effects of DES, as well as the many other side effects that other DES mothers, children, grandchildren, and great-grandchildren continue to deal with, only because “modern medicine” believed that medications were not able to cross from an expectant mother to her unborn child. This led to not only one generation being impacted by the harmful effects of the first synthetically manufactured estrogen which was given to pregnant women between 1940 to 1971 to prevent miscarriage and related complications of pregnancy.   Su explains how her own experience caused her to look deeper into medications which are prescribed, as well as potential side effects. Her research and due diligence went into high gear when her nephew who was living with her and her husband, was diagnosed with ADHD at the age of 12. He was subscribed large doses of approved ADHD medications, the doctors told Su and her family that he would keep trying various medications to “get that kid under control.” When Su asked what the potential side effects were, the doctor assured her that there weren't any. When she asked to see the studies, he laughed and said there weren't any, but again reassured her that they were perfectly safe. Download this informative episode to hear Su's story, and discover how she and her family were able to help their nephew deal with his ADHD without medication, the importance and impact of healthy living, how to become your own health advocate, how to get involved with your own medication regime by collaborating and communicating with both your doctor and pharmacist, why it's important to consider your options, how to balance the benefits with the risks of medications.         https://medshadow.org/ https://www.facebook.com/medshadow.foundation https://www.tiktok.com/@medshadow_foundation?lang=en https://www.instagram.com/medshadowfoundation/?hl=en https://twitter.com/Med_Shadow? https://www.linkedin.com/in/suzannerobotti/ https://www.youtube.com/user/MedShadowFoundation  

In this episode, William Green chats with Bob Robotti, a great investor who's crushed the S&P 500 over the last 40 years. Bob, the President & Chief Investment Officer of Robotti & Co, explains why he believes we're in a “new golden age” for active, value-oriented investors (not index funds); why he expects persistently high inflation; why he's betting heavily on the resurgence of Old Economy businesses; & how he's positioned to profit from “the first truly global energy crisis.” IN THIS EPISODE YOU'LL LEARN: 00:00 - Intro 12:18 - How Bob Robotti lucked into the ideal job for an aspiring investor.  33:19 - How working for Mario Gabelli was like a one-on-one MBA. 40:22 - Why Bob thinks we're in a new golden age for savvy stockpickers.  40:48 - Why he's betting heavily on a “metamorphosis of the Old Economy.” 46:16 - How globalization is evolving as China loses its edge. 50:49 - Why energy-intensive US companies have a long-term advantage. 57:33 - Why owning the “Magnificent Seven” looks like a risky bet. 58:23 - What an era of persistently high inflation means for investors. 1:03:35 - How value investing has changed. 1:19:01 - How Bob is positioned for “the first truly global energy crisis.” 1:38:06 - How his life has been enriched by helping young people. 1:43:45 - What he learned from his wife and father about facing adversity. Disclaimer: Slight discrepancies in the timestamps may occur due to podcast platform differences. BOOKS AND RESOURCES Bob Robotti's investment firm, Robotti & Co. Bob Robotti's writings. Check out MedShadow.org, a health-related site founded by Bob Robotti's wife, Suzanne. William Green's podcast with John Spears: Winning the Long Game | YouTube Video. William Green's book, “Richer, Wiser, Happier” – read the reviews of this book. Follow William Green on X. Check out all the books mentioned and discussed in our podcast episodes here. Enjoy ad-free episodes when you subscribe to our Premium Feed. NEW TO THE SHOW? Follow our official social media accounts: X (Twitter) | LinkedIn | | Instagram | Facebook | TikTok. Browse through all our episodes (complete with transcripts) here. Try our tool for picking stock winners and managing our portfolios: TIP Finance Tool. Enjoy exclusive perks from our favorite Apps and Services. Stay up-to-date on financial markets and investing strategies through our daily newsletter, We Study Markets. Learn how to better start, manage, and grow your business with the best business podcasts.  SPONSORS Support our free podcast by supporting our sponsors: River Toyota CI Financial Sun Life AFR The Bitcoin Way Industrious Briggs & Riley Meyka Public Vacasa American Express iFlex Stretch Studios Range Rover Fundrise USPS Shopify HELP US OUT! Help us reach new listeners by leaving us a rating and review on Apple Podcasts! It takes less than 30 seconds, and really helps our show grow, which allows us to bring on even better guests for you all! Thank you – we really appreciate it! Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://theinvestorspodcastnetwork.supportingcast.fm

BONUS EPISODE: Keynote Q&A with Bob Robotti, Founder and CIO of Robotti & Co. - this interview was recorded live at the Planet MicroCap Showcase: VEGAS 2024. Topics covered: defining MicroCap/Small-Cap, Robotti's strategy, opportunity set for stock pickers, old economy stocks, all followed by Q&A from the audience. For more information about Bob Robotti and Robotti & Co., please visit: https://www.robotti.com/ Chapters: [0:00] Introduction + Episode sponsor: Daloopa [2:12] How Bob defines MicroCap, Small-cap / Robotti's strategy [6:49] Opportunity set for stock pickers [13:04] Magnificent 7 / AI; stock pickers will win the next decade [19:00] Old economy stocks (industrial businesses) [24:43] Q&A from the audience This episode is sponsored by our friends at Daloopa Hey there, fundamental analysts - Are you tired of the endless grind of updating financial models, scrubbing documents, and hard coding? Let's talk about something that could transform your workflow—Daloopa. Daloopa delivers perfect historicals for thousands of public companies. That means every KPI, operating data, financial metric, adjustment, and guidance—all at your fingertips. And here's the best part: Daloopa updates your models in near real-time, which is especially important during earnings season, tailored to your modeling format and style. Imagine never having to update your models again. With Daloopa, you can reclaim your time and focus on what really matters—analysis and research. Want to learn more? Create a FREE account at Daloopa.com/YAV All information presented in all forms at the Planet MicroCap Showcase or in press releases, videos, emails, or otherwise posted on its website, stocknewsnow.com or YouTube channel (the “Outlets”) is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Stock News Now, SNN Inc., and the Planet MicroCap Showcase, and their representatives are not licensed brokers, broker/dealers, market makers, investment bankers, investment advisers, analysts, or underwriters.

As women go through menopause and beyond, hormonal changes affect how they react to medications! Join Jeanne as she speaks with Suzanne Robotti about safe treatments for women during and after menopause. Women should work closely with their doctors to manage their medication and deal with any risks or side effects! Here are the things to expect in the episode:The effects of drugs and their side effects as people age.How do medications impact women as they navigate through menopause and beyond?Consulting pharmacists and drug reviews.Why is it important for women to exercise caution when considering herbal supplements?And much more! About Suzanne:Suzanne Robotti started MedShadow Foundation in 2013 because she was harmed by a medicine called DES (diethylstilbestrol) that was given to her mother while pregnant and, as a result, was unable to have children. Generations later, this hormone disruptor has been found to cause rare cancers, autoimmune diseases and infertility.In 2017, Robotti was appointed to the FDA Advisory Committee on Drug Safety and Risk Management, joining a panel of doctors and pharmacists as the sole consumer representative. Together, the Committee reviews research and decides if a drug is safe enough for use. Connect with Suzanne Robotti!Website: https://medshadow.org/Healthline: https://www.healthline.com/health/anticholinergicsBeers List (Printable Version): https://www.pharmacyquality.com/wp-content/uploads/2019/05/Beers-List-350301.pdf Connect with me, Jeanne Andrus!Website: https://menopausematterspodcast.com/Email: jeanne@menopause.guruFacebook: https://www.facebook.com/Menopause.Matters.The.PodcastTalk with Me: https://mg.menopause.guru/book-invitationSign up for the workshop at https://menopause.guru/holiday Find out how you can take control of your menopause journey!Schedule your FREE consultation now at menopause. guru/consult. Think Again! Clearing Away the Brain Fog of Menopause can be purchased at https://www.amazon.com/Think-Again-Clearing-Brain-Menopause-ebook/dp/B076H4PJ7G/ Music from #Uppbeat (Free For Creators!): Aurora by Roo Walker https://uppbeat.io/track/roo-walker/aurora?rt=uc-referralLicense code: 6BNDRM6ZKOHCYGCB

Discover the untold truths of medication safety as we hear from special guest Suzanne Robotti from MedShadow in this third installment of the ‘Medication March' series.We explore the often-hidden complexities that come with newly approved drugs and Su's experience on an FDA advisory committee approving the drug Wogovy for diabetes. We discuss prioritizing safety and advocacy in the realm of medication. Su sheds light on a startling statistic: a considerable proportion of newly approved drugs come with concerning health warnings several years post-approval.We delve in to address the concerning trend of overprescription and the potential toxic effects of diabetes medications. Importantly, we encourage you to take charge of your health and not shy away from probing your doctor or healthcare team about the necessity and risks of prescribed medications.It's up to you to be the boss of your own medicines, and we share ways in which you can do that!This series is all about ensuring:>> You realize you're not alone in the challenges you may face with healthcare professionals and the healthcare system. >> You have the information and knowledge about diabetes medications that you need to make informed decisions.>> You know how to have meaningful dialogue with your doctor to foster a collaborative relationship that actually leads to better health outcomes for you.>> You become your own best advocate and take charge of your diabetes health. Please get involved in this conversation!Visit Type2DiabetesTalk.com and leave your comments on any of the Medication March episodes, or leave us a voice message or send an email with your questions and experiences. CHAPTERS2:37 Surprising Medication Facts4:41 Federal Drug Administration Approvals8:02 Conflicts of Interest15:59 Medication Risks and Diabetes Reduction20:08 Taking Charge of Your Own HealthFor show notes and resources, please visit: https://Type2DiabetesTalk.comTo share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/messageExplore our proven programs and services, visit: https://Type2DiabetesTalk.com/programsSubscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe

In this episode, the second installment of our ‘Medication March' series, you're invited to explore a path in diabetes management that goes beyond just medication. This special episode features Suzanne Robotti from MedShadow, who shares her personal medication journey, a story that underscores the importance of being informed about the potential long-term implications of prescription medications. The episode highlights the startling reality of the sheer number of people who take prescription drugs, pointing to an over-reliance on medication that often leads to negative outcomes such as emergency hospital visits, with diabetes medications being a predominant driver.As you listen, you're encouraged to consider the power of diet and lifestyle changes in managing your prediabetes and type 2 diabetes, which can be more effective than medications. The discussion motivates you to question your prescriptions, recognizing side effects, seeking alternatives, and understanding the risks of the 'drug cascade' – taking new medications to address side effects of existing ones.This series is all about ensuring:>> You realize you're not alone in the challenges you may face with healthcare professionals and the healthcare system. >> You have the information and knowledge about diabetes medications that you need to make informed decisions.>> You know how to have meaningful dialogue with your doctor to foster a collaborative relationship that actually leads to better health outcomes for you.>> You become your own best advocate and take charge of your diabetes health. Please get involved in this conversation!Visit Type2DiabetesTalk.com and leave your comments on any of the Medication March episodes, or leave us a voice message or send an email with your questions and experiences. CHAPTERS1:59 Su's Medication Journey7:27 Overreliance on Medications10:16 The Dark Side of Meds15:05 Don't Overlook Any Side Effects18:29 Communicating With Your Doctor or PharmacistFor show notes and resources, please visit: https://Type2DiabetesTalk.comTo share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/messageExplore our proven programs and services, visit: https://Type2DiabetesTalk.com/programsSubscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe

ADHD IS A GENETIC ADVANTAGE is an episode with my guest Su Robotti, a Consumer Health Advocate and the founder of the MedShadow Foundation, launched in 2013. She did so after she was harmed by a medicine called DES (diethylstilbestrol) that was given to her mother while pregnant and as a result was unable to have children. Generations later, this hormone disruptor has been found to cause rare cancers, autoimmune diseases and infertility. In 2017 Robotti was appointed to the FDA Advisory Committee on Drug Safety and Risk Management, joining  a panel of doctors and pharmacists as the sole consumer representative. Together, the Committee reviews research and decides if a drug is safe enough for use. Su and I are going to do a deep dive on such topics as the risks of side effects from medicines; questions to ask your doctor about meds; increased risks of meds for children and the FDA's drug approval process in general as well as her role on the FDA Advisory Committee. Mentioned Links: https://www.desaction.org https://www.cochrane.org https://pubmed.ncbi.nlm.nih.gov https://newsarchive.berkeley.edu/news/media/releases/99legacy/5-5-1999.html https://medshadow.org/associates/suzanne-robotti/ For more information on this podcast, please visit www.adhdisover.com

Suzanne Robotti is a DES baby. If you are not familiar with that term, you will learn what it means during this conversation and how it shaped Suzanne's life path. She shares her advice about what to do when you are given a diagnosis and treatment plan and what she does to support anyone looking for non-biased medication information. To learn more about medication side effects, long-term effects, risks and benefits go to https://medshadow.org/. ********************** Kim Benoy RN is a wife, mom, educator and Certified Aromatherapist who has a passion for helping women over 40 live every moment. She is offering a new way to support health and wellness through her new video channel on her website www.midlifewithcourage.com. You can get the first two months 50% off by using the code on the website.

Are you aware of the hidden dangers that may come with taking medications? It's crucial to understand the importance of being your own health advocate when it comes to managing your health and well-being. In this episode, Suzanne Robotti, founder of MedShadow.org and an FDA consumer representative on drug safety and side effects, shares her personal experience of being harmed by a medication and the importance of being your own health advocate. We discuss the risks and side effects of medications, the need for awareness and research, and the power of listening to your body. Suzzane emphasizes the importance of understanding the long-term effects of medications and making informed decisions about your health.  Listen to the full episode to immerse yourself in her captivating narrative and gain valuable knowledge that could potentially reshape your approach to healthcare. "Your body is telling you not to eat it. And there's probably a reason why your body is telling you not to eat it. Listen to your body." - Suzanne Robotti Topics Covered: 0:00:02 - Introduction and discussion about fitness 0:00:30 - Suzanne's experience with a trainer and physical improvement 0:03:02 - Suzanne's overall health and well-being 0:04:04 - Suzanne's background and the impact of the drug DES on her fertility 0:06:53 - Long-term effects of DES on different generations 0:08:06 - Emotional and psychological impact of DES on Suzanne 0:10:16 - MedShadow's mission and approach to drug information 0:12:01 - Balancing doctor's advice with personal choice and research 0:14:35 - School principal insists on medication for ADHD 0:15:45 - Suzanne's seeks advice and learns about ADHD medication side effects 0:16:20 - Specialist prescribes Ritalin and suggests other drugs 0:18:47 - Suzanne's opts not to medicate her nephew and seeks alternative diagnosis 0:21:49 - Cautions against misinformation on the internet 0:22:59 - Encourages listening to the body's cues 0:26:01 - Consider exploring other options before medication 0:26:14 - Lifestyle changes to improve health and well-being 0:27:49 - The prescribing cascade and the dangers of dependency 0:28:38 - Choosing natural methods over medication for digestion issues 0:29:38 - Taking steps to avoid medication when possible 0:30:17 - Falling in love with fitness and self-care 0:30:44 - Contact information for further discussion 0:31:15 - Nonprofit organization and support from pharmaceutical companies Key Takeaways: Importance of understanding the risks and benefits of prescribed drugs The negative effects of opioids on the body Importance of personal decision-making What are the body's regenerative abilities Importance of sleep hygiene and lifestyle choices Connect with Suzanne Robotti: ⁠Website⁠ ⁠Facebook⁠ ⁠Instagram⁠ ⁠TikTok⁠ Twitter Youtube LinkedIn Connect with Sherry Shaban: ⁠Website⁠ ⁠Facebook⁠ ⁠Instagram⁠ ⁠TikTok⁠ ⁠LinkedIn⁠ YouTube If you're struggling with self-sabotaging behavior and other non-serving habits that have been keeping you from hitting your health goals, I'd like to invite you to join me in Transformation in Paradise: Metamorphosis Greece this October 12–19, 2024, in Lefkada. Visit www.sherryshaban.com/retreats for more details. If this sounds like something you'd like to learn more about, email me at sherry@sherryshaban.com and let's get in touch to go over all the details and answer your questions to determine if this retreat is the right fit for you. Keep it up, Athletes! Sherry

Why are we swallowing so many drugs? Are they necessary? Are they safe? Su Robotti created MedShadow.org to protect lives by uncovering the hidden risks of medicines so everyone has the ability to make informed decisions about the risks, benefits, and alternatives to medicine. Today we explore the lesser-known stories behind medicine, the side effects they may harbor, and the long-term impact they can have on our lives!

Su Robotti started the MedShadow Foundation in 2013 as a result of being harmed by DES, a med that was given to her mother while pregnant rendering her infertile. In 2017, Su was appointed to the FDA Advisory Committee on Drug Safety and Risk Management. She discusses the foundation's website medshadow.org and it's usefulness for people to research med side effects to discuss with their provider prior to consumption.

Tom Gayner stops by The Business Brew to discuss a number of things. You can see the detailed show notes for specifics, below the stratosphere.io sponsor copy. In summation, Bill has wanted to interview Tom for a long time but didn't know how to make the interview unique. We think this interview covers some topics Tom has not discussed elsewhere. Please consider attending Markel's annual meeting. On Wednesday, May 17th, from 9-10:30 the good folks at Robotti and Co. are hosting an investor panel. There will be 8-12 “best ideas” presented. The Markel annual meeting will follow that event. Food, music, and beer will follow the Markel annual meeting. We hope you enjoy this podcast episode. This episode is sponsored by Stratosphere.io. Stratosphere.io is a web based terminal that has financial data, KPIs, links to filings, hedge fund letters, etc. A key differentiator is Stratosphere.io's segment data and KPIs, which are triple checked for accuracy. Stratosphere saves users time, enables easy comparisons between companies, and offers company specific metrics such as subscriber counts, numbers of locations, etc. Head over to Stratosphere.io for a free trial. Should you want to sign up for a paid offering please use the promo code BREW for 15% off. Thank you to the team at thepodcastconsultant.com for producing the show. Detailed Show Notes - 5:00 – The goal of the Markel annual event 7:30 – Tom's background 9:35 – Blue capital and orange capital 17:05 – Creating dealflow and how long that takes 20:10 – Learning how to delegate 24:55 – What happened with the ILS transactions 33:20 – Searching New Highs and New Lows 38:40 – How investing at Markel does or does not impact Tom's investing style 34:20 – The intertwining of Berkshire, Markel, and The Davis Funds 43:50 – The importance of relationships 48:40 – The Big Lebowski 49:10 – What traveling to India has taught Tom 56:25 – Decisions in March 2020 and how being at Markel impacted Tom 1:02:20 – How was the transition from Co-CEO to CEO 1:05:40 – How to be a deserving spouse Book Mention: The Way We Live Now https://www.amazon.com/Way-Live-Now-Penguin-Classics/dp/0140433929/ref=asc_df_0140433929/?tag=hyprod-20&linkCode=df0&hvadid=475771750252&hvpos=&hvnetw=g&hvrand=16689022937612321338&hvpone=&hvptwo=&hvqmt=&hvdev=c&hvdvcmdl=&hvlocint=&hvlocphy=9011844&hvtargid=pla-469518675534&psc=1

Bob stops by The Business Brew to discuss his early career, what he has learned over his career, investing in cyclical businesses/industries, and his biggest investment "loser." This conversation is filled with good lessons and we hope you enjoy. Robert Robotti is the President and Chief Investment Officer of Robotti & Company. Prior to forming Robotti & Company, Incorporated in 1983, Bob was a vice president and shareholder of Gabelli & Company, Inc. He worked in public accounting before coming to Wall Street and is currently an inactive CPA. Bob holds a BS from Bucknell University and an MBA in Accounting from Pace University. Some of Bob's areas of coverage include Special Situations, Energy Industry and Home Building. Bob is the principal of the managing member or general partner of several investment vehicles. Bob currently serves on the Board of Directors of a NYSE-listed real estate company, AMREP Corporation, located in Germantown, PA; as Chairman of the Board of Directors of Pulse Seismic Inc., a seismic data licensing business located in Calgary, Alberta; as an Independent Director of PrairieSky Royalty, a Toronto Stock Exchange listed company located in Calgary, Alberta, having one of the largest portfolios of sub-surface mineral rights in western Canada; as a recently elected Director of NYSE-listed Tidewater, Inc. which owns and operates one of the largest fleets of OSVs (Offshore Support Vessels) in the industry; and was previously on the Board of Directors of BMC Building Materials Holding Corporation, prior to the completion of its merger with Stock Building Supply Holdings, Inc. on December 1, 2015; and Bob had served on the Board of Panhandle Oil & Gas Company, a NYSE-listed diversified mineral company located in Oklahoma City through May 1, 2020. In addition, he serves on the Boards of many non-profit organizations where he generously donates his time and expertise. Previously, Bob was a member of the Securities and Exchange Commission's Advisory Committee on Smaller Public Companies, established to examine the impact of Sarbanes-Oxley Act and other aspects of the federal securities law. This episode is sponsored by Stratosphere.io. Stratosphere.io is a fantastic web based research terminal for company specific metrics like KPIs and segment revenues. Head over to Stratosphere.io to try the product for free OR use the promo code BREW for 15% off Stratosphere's premium product. Detailed Show Notes Below: 3:20 - Bob's early career 6:35 - How Bob ended up as CFO of Gabelli and Company 10:25 - Bob's evolution as an investor 14:25 - How tough times create better businesses and Builder's FirstSource discussion 18:20 - Holding equities and Bob's biggest loser 29:50 - Why earnings drive liquidity 31:20 - How Bob implements his takeaways from his biggest loser 33:20 - Why Bob got excited about the Revenge of the Old Economy in 2020 35:20 - The case for Olin Corp 43:50 - How Bob's “margin of safety” comes from his portfolio company's asset bases 45:50 - Bob's energy outlook; this is an around the world oil discussion that lasts ~11 minutes 1:02:20 - Why reshoring makes sense 1:04:30 - Did Volker really succeed? 1:05:20 - Why China is no longer deflationary 1:09:20 - The nuance of selling 1:11:20 - The potential perils of linear thinking

On todays episode, I'm here with Jack Robotti and Asher Kennel to talk about their childhood friendship and many more fun topics. Make sure to tune in and listen to this super exciting episode with two of my best friends. Thanks for listening! Check out our website and follow all socials! https://dailydoseofcurlypodcast.buzzsprout.com

Subsea 7 delivers offshore projects and services for the energy industry worldwide. The company provides project management for heavy machinery offshore projects. This includes everything from design to installation. Listen as Brett and Ryan ask Bob questions about the company, its business model, and valuation. Enjoy the show! ***************************** Interested in becoming a member of 7investing? Subscribe with code “MONEY” and get $100 off your annual subscription for life: https://7investing.com/checkout/ ****************************** Want updates on future shows and projects? Follow us on Twitter: https://twitter.com/chitchatmoney Interested to see more of Bob's work? Follow him on Twitter here: https://twitter.com/BobRobotti?s=20&t=CyIvo0ZEdvDVvNxruG_i3w Contact us: chitchatmoneypodcast@gmail.com Timestamps Subsea 7 | (9:27) Differentiation | (30:35) Disclosure: Chit Chat Money hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation. Brett Schafer and Ryan Henderson are general partners and portfolio managers at Arch Capital. Arch Capital and its partners may hold securities discussed on this show.

I sat down with my friend Robert “Bob” Robotti, the president and chief investment officer of Robotti and Company. Bob is an expert in special situations, the energy industry, and home building. In this episode, he shares about what he's learned throughout his career, what he sees for the future, and advice for new investors. Investing the Templeton Way with Lauren Templeton is a podcast that explores the world's most intriguing investment topics from the overseas markets to mastering our own minds. Gather investment wisdom and educate yourself as you listen to interviews with exclusive managers, executives, and entrepreneurs on a wide range of engaging topics.Review full show notes and resources mentioned in today's episode at http://investingthetempletonway.com/Connect with Bob:Website: https://www.robotti.com/Twitter: @BobRobotti Mentioned in this Episode:https://www.barrons.com/articles/as-rates-rise-the-old-economy-has-its-revenge-51643362201The information presented in this podcast or available on the website is not intended as and shall not be construed as financial advice. This podcast is produced for entertainment value. Investing is inherently risky. And I encourage you to seek financial advice from a professional who is aware of the facts and circumstances of your individual situation.The information presented in this podcast or available on the website is not intended as and shall not be construed as financial advice. This podcast is produced for entertainment value. Investing is inherently risky. And I encourage you to seek financial advice from a professional who is aware of the facts and circumstances of your individual situation.

Esko koki vääryyttä liikenteessä, mutta kuka loppupeleissä olikaan väärässä? Kaverin puolesta kyselen -osiossa autetaan Astaa, jonka ongelmaan Suvi samaistuu täysin. Suvin kolme sanaa saa Eskon näkemään Suvin mustavalkoelokuvana. Suvi hämmentää komposti tarinalla, joka vei turhaa kaikkien aikaa. Myös robotit ja ensitreffit puhuttavat studiossa. Kuuntele Radio Novan Iltapäivän parhaat TÄSTÄ.

Bob Robotti, founder of Robotti Advisors, discusses his thesis on Westlake Corporation (WLK) and why he thinks "old economy" stocks are poised for a comeback.My notes on WLK: https://twitter.com/AndrewRangeley/status/1513885052974899200?s=20&t=QiY-1L2H5U3GZ-S5YjGFwwChapters0:00 Intro2:50 WLK Overview6:10 Diving into WLK's segments and products10:45 WLK's favorable supply demand dynamics14:40 WLK's valuation18:55 WLK's control shareholders and family ownership22:15 How can WLK acquire so accretively?28:00 WLK's capital allocation31:45 Do WLK's segments make sense together?39:00 Why buy WLK versus peers?41:40 BLDR and the building products distributors44:45 Why "don't buy cyclicals at the top" might be wrong today51:00 What happens if tech stocks stumble / Revenge of the old economy

Обзор новых роботов для сельского хозяйства от Phoenix, Robotti, Robi, Carbon Robotics, WeLASER, Future Acres, Sitia, NARO, Ripe Robotics, H2L Robotics, Iron, Exel Industries, PeK Automotive, Yanmar, Damcon #Aigro, AutoAgri, Earth Automations, Dragone и Grain Weevil.

Riccardo Lionetto analizza e commenta il momento dei rossoneri di Giunti, reduci da un momento positivo in campionato e con tanti giovani in rampa di lancio che sono destinati a diventare molto interessanti nei prossimi mesi.

En person som har hand om och fördelar arbetsuppgifter till robotar. Så beskriver Jonas Engström, forskare på Rise i Uppsala, en möjlig framtida bonde. Hur bondeyrkets attraktivitet förändras när lantbrukets maskiner klarar sig utan förare återstår att se, men i det här avsnittet av Lantbrukspodden följer Land Lantbruks reporter Anna Ellström med när maskinen Robotti en blåsig höstdag i hackar ogräs i på Ultunaområdet. Har du synpunkter eller förslag på ämnen och gäster till podden? Mejla oss på lantbrukspodden@landlantbruk.se.

Riccardo Lionetto analizza e commenta l'ennesima sconfitta stagionale della formazione di mister Giunti: quali le cause e chi sul banco degli imputati? Ecco la risposta

We chat with Thomas Beach about the future of the farming and Agriculture industry. A brilliant insight into how framing will develop over the coming years with the advancement of AI, Robotics and Data Analytics, these advancements will allow farmers to focus on diversifying, and becoming more environmentally friendly. Thomas is actively working towards changing the industry through his business Autonomous Agri Solutions which imports and sells ROBOTTI, an autonomous light weight vehicle that can be used to assist with all sorts of farming activities. We discuss the future of Farming and the skill sets the industry is going to need going forward, from Marketing, to Data analytics, to Engineers, to business development roles. The developments in agriculture will truly open the industry up to so many new people who can bring a new perspective, ideas and skill sets. A pleasure to chat with Thomas.   

Rachel talks to Suzanne Robotti, the President and Founder of the MedShadow Foundation. MedShadow protects lives by uncovering the hidden and minimized risks of medicines so that everyone has the ability to make truly informed decisions about the risks, benefits, and alternatives to medicines. More at www.medshadow.org. To learn more about the Fourth Cause Campaign, visit https://fourthcause.org/ and find out how you can share your story and help spread awareness. #fourthcause

An international educational podcast for professionals and patients all about the finer details of rhinoplasty. In each episode, we travel the globe talking to world-leading plastic surgeons, hearing their unique stories, and learning from their experiences.

An international educational podcast for professionals and patients all about the finer details of rhinoplasty. In each episode, we travel the globe talking to world-leading plastic surgeons, hearing their unique stories, and learning from their experiences.

Visit our website: www.progresivnasuza.com - Instagram: www.instagram.com/progresivna_suza SoundCloud: www.soundcloud.com/progressivetales Facebook Group: www.facebook.com/groups/progresivnasuza Facebook Page: www.facebook.com/progrsuza - Worldwide shop: www.redbubble.com/people/progresivnasuza/shop Serbian shop: www.progresivna-suza.shop.brendly.rs - PayPal donations: www.paypal.me/progresivnasuza - If you have any question, you can find us on: office@progresivnasuza.com - Podcast Inquiry podcast@progresivnasuza.com

Kaamos iskee! Tässä jaksossa keskustellaan syysmasistelusta, vinkataan Youtube-kanavia, joita sun pitäis jo seurata sekä mietitään onko ihminen hullu jos se ei moppaa lattioita! See acast.com/privacy for privacy and opt-out information.

Tässä jaksossa pureudutaan kotitöiden ihmeelliseen maailmaan. Puhutaan metatöistä ja niiden jakautumisesta kotitalouksissa. Kuka teillä suunnittelee kauppalistan? Kumpi hoitaa lahjat synttäreille?

Tämä heinäkuu on todella jännää aikaa, koska kaikkiaan kolme avaruusalusta lähtee maapallolta kohti Marsia. Jokainen niistä on omalla tavallaan todella kiinnostava: Nasan Perseverance-kulkija on kunnianhimoisin ja mutkikkain koskaan tehty Marsin pinnalle lähetettävä tutkimusrobotti, kiinalaisten Tianwen-1 on heidän ensimmäinen Mars-kulkijansa ja Yhdistyneistä arabiemiraateista tulee uusi, hieman yllättäväkin Mars-luotaimen lähettävä maa. Tiedeykkösessä tutkaillaan näitä kaikkia, mutta keskitytään ennen kaikkea Nasan laitteeseen: Noin tonnin massaltaan oleva kulkija poimii Jazero-kraatterista näytteitä tulevaisuudessa Maahan tuotaviksi. Kulkija pakkaa ne pieniin kapseleihin, joita se pudottelee matkalleen myöhemmin keräiltäväksi ja maanpäällisiin laboratorioihin laukaistavaksi. Jezero on eräs kiinnostavimmista paikoista Marsin pinnalla, sillä se on noin 49 kilometriä halkaisijaltaan oleva kraatteri, jonka pohjalla on ollut kauan aikaan sitten vettä. Kaikki alukset lähetetään matkaan nyt heinäkuussa siksi, että lokakuussa Maa ja Mars ovat lähellä toisiaan. Kun kumpikin planeetta kiertää radoillaan Aurinkoa, ovat ne lähekkäin vain noin kahden vuoden välein. Silloin matka Maasta Marsiin käy helpoiten. Ohjelmassa ollaan Perseverancen tehneessä Nasan tutkimuslaitoksessa Jet Propulsion Laboratoryssä ja jutellaan myös Ilmatieteen laitoksella työskentelevän Maria Hiedan kanssa – kulkijassa on myös kaksi suomalaista mittalaitetta, joiden tekemisestä Maria vastasi. Heinäkuun aikana luotaimien laukaisupäivämäärät ovat hieman muuttuneet ja tarkentuneet verrattuna ohjelmassa mainittuihin. Arabiemiraattien luotaimen laukaisua japanilaisella kantoraketilla on lykätty heinäkuun 14. päivästä perjantaihin 17.7. laukaisupaikalla olleen epäedullisen sään vuoksi. Nasan Perseverance -kulkijan laukaisu tapahtuu näillä näkymin 30.7., koska kantoraketin lähtövalmisteluihin kului odotettua enemmän aikaa. Kiinalaisen Tianwen-1:n laukaisu tapahtuu puolestaan näillä näkymin 23.7. Toimittajana on Jari Mäkinen Kuva: Nasa

En Basta Chicos nos visita Juan Rugani con el Doc. Robotti de Conducta animal médico veterinario y Etólogo clínico acompañado por su perra golden Cleo

AgroIntelli komt met nieuwe Robotti, New Holland verkoopt meeste trekkers in Nederland en Natuition Violette-robot boort onkruid uit sportveld. Dit en meer in het Mechaman Maandoverzicht van februari 2020.

Perrrrjantai on koittanut NRJ:n Aamussa! Aina sitä kuvittelee, että tietyt asiat eivät sattuisi omalle kohdalle, mutta eilen Jannen pilvilinna mureni. Jere taas suunnitteli itsellensä pikapukua ja lihaporkkanoita! Mielessä myös epäsuosittujen asioiden arvostus, tupla-Korona ja denssi-mies!

Hello Listeners, Today is a very special episode with Bob Robotti, president and CIO of Robotti & Company. He founded Robotti & Company since 1983. Before this he was vice president and shareholder of Gabelli & Company, Inc. He is a graduate of Bucknell University and earned his MBA in Accounting from Pace. Bob is also a CPA. In today's episode we discuss his latest idea. Enjoy and thanks for the listen!

Hello listeners, Today is a very special episode with Bob Robotti, president and CIO of Robotti & Company. He founded Robotti & Company since 1983. Before this he was vice president and shareholder of Gabelli & Company, Inc. He is a graduate of Bucknell University and earned his MBA in Accounting from Pace. Bob is also a CPA. In today's episode we discuss his overall approach and why there is still opportunity for value investors today. Enjoy and thanks for the listen!

SuomiRockin Aamu on kesälomilta takaisin! Aamussa tänään: Robotti-imuri on karmea keksintö. Shirly kävi Hangon regatassa ensimmäisen ja viimeisen kerran.

Nyt keskustellaan roboteista! Robotiikan asiantuntija Cristina Andersson on perehtynyt vuosien saatossa erilaisiin robotteihin ja niiden kehitykseen. Teollisuudesta tuttujen perinteisten robottien rinnalle ovat tulleen modernit robotit, jotka pystyvät liikkumaan ihmisten keskuudessa suorittaen erilaisia tehtäviä ja samalla keskustellen ihmisten kanssa aistien heidän ilmeitään ja tunteita. Kuuntele tämä jakso, niin tiedät mihin robottien kehitys on menossa tekoälyn ja aistimuksia tuottavien sensoreiden myötä.

Kaumatua, una community di nonni volontari per aiutare i giovani. Odile Robotti ci racconta come la tecnologia è sì un punto di distacco tra generazioni diverse, ma può essere e dovrà essere invece un punto di contatto per mettere l'esperienza al servizio degli altri.

Toimittajana Olli Haapakangas Puheenaiheita: Astmaatikon ilmastopakolaisuus. Robotti vie kaikkien työt. Digikiima huolettaa, ainut pankki sulkee. Mistä töitä? Norjasta töitä! Tiltu ja Paskia. ei muuta ku kuokkimaan! Pah pah, pisti viisas sika. Todellisia ilmastotekoja. Huonot halot. Mustikkametsää muistellen. Kirkon verot, tyytyväinen taksiasiakas, lastenrääkkääjät linnaan! Leskeneläkettä kaivaten. Gallupit ja lonkerot. Muutoksia vaalijärjestelmään.

Tokiolaisen AI Research Centerin vanhempi tutkija Kristiina Jokinen on työskennellyt vuosien ajan robottien kommunikaation parissa. Hän osaa kertoa, mitä robottien on opittava sanojen lisäksi, voidakseen keskustella ihmisten kanssa. Kaksiosaisen robottien puheenopetusta käsittelevän ohjelman jälkimmäisen osan ovat toimittaneet Pasi Heikura ja Tina Cavén

Kuinka robotti voisi oppia ymmärtämään ja tuottamaan puhetta, kun edes ihmiset eivät aina ymmärrä toisiaan? Haasteena siinä onkin elekielen, ilmeiden ja piilomerkityksien avaaminen tekoälylle. Palvelurobottien puheohjauksen ja puheen tuottamisen kehitystyö opettaa tutkijoille paljon myös ihmisten käytöksestä ja kommunikoinnista. Kaksiosaisen ohjelman ensimmäisessä osassa Tokiolaisen AI Research Centerin vanhemman tutkijan Kristiina Jokisen kanssa keskustellaan robottien ja ihmisten kielestä ja ensi viikolla kaikesta muusta, mitä kommunikaatioon tarvitaan. Ohjelman ovat toimittaneet Pasi Heikura ja Tina Cavén.

Autrice del libro «Il talento delle donne» nonché moderatrice del blog «Leadership Femminile», Odile Robotti analizza le differenze tra leadership femminile e leadership maschile, citando gli stereotipi di genere più comuni.

Yleisesti ajatellaan, että koneita eivät ihmisoikeudet koske. Ne eivät ole ajattelevia tai tuntevia otuksia. Vai ovatko? Esimerkiksi maailmalle hiljattain esitelty Sofia-robotti osaa laulaa, auttaa tekemään valintoja kaupassa, hoivaa vanhuksia, leikittää lapsia ja tutkii asioita. Ansaitseeko Sofia sittenkin ihmisen kaltaista kohtelua? Mitä roboteista tulisi ajatella etenkin teologisesta näkökulmasta, jossa ihmisellä on erityinen arvo ja rooli Jumalan kuvana? […] Areiopagin podcast 09: ”Robotti voi olla Jumalan kuva” on Areiopagi sivuston artikkeli.

Laitilan terveyskodin fysioterapeutti ja Paulina Iiskala kävelyttää potilaitaan yhteistyössä Lokomat-robotin kanssa. Lisää >> http://ift.tt/2nmcR19

Impulssi-podcastin seitsemännessä jaksossa tarkastellaan robotiikkaa ja robotisaatiota. Minkälainen ilmiö robotisaatio on ja miten se vaikuttaa elämäämme? Minkälaista robotisaatiota ja minkälaisia robotteja on olemassa jo nyt? Millä tavoin robotit vaikuttavat terveydenhoidon ja liikenteen aloilla? Entä mitä eettisiä kysymyksiä robotisaatioon liittyy? Lisäksi jaksossa pohditaan, kuinka Suomi voi tulla tulevaisuudessa robotiikan kärkimaaksi. Minkälaisia toimia kärkimaaksi eteneminen vaatii ja… The post Onko sinunkin työparisi tulevaisuudessa robotti? appeared first on ImpulssiLVM.

Impulssi-podcastin seitsemännessä jaksossa tarkastellaan robotiikkaa ja robotisaatiota. Minkälainen ilmiö robotisaatio on ja miten se vaikuttaa elämäämme? Minkälaista robotisaatiota ja minkälaisia robotteja on olemassa jo nyt? Millä tavoin robotit vaikuttavat terveydenhoidon ja liikenteen aloilla? Entä mitä eettisiä kysymyksiä robotisaatioon liittyy? Lisäksi jaksossa pohditaan, kuinka Suomi voi tulla tulevaisuudessa robotiikan kärkimaaksi. Minkälaisia toimia kärkimaaksi eteneminen vaatii ja… The post Onko sinunkin työparisi tulevaisuudessa robotti? appeared first on .

Steal my job -podcastin ensimmäisessä jaksossa Marjaana Toiminen keskustelee työn tulevaisuudesta Henkka Hyppösen kanssa.

Robert Robotti is the President of Robotti & Company. Prior to forming Robotti & Company, Incorporated in 1983, Bob was a vice president and shareholder of Gabelli & Company, Inc. He worked in public accounting before coming to Wall Street and is currently an inactive CPA. Bob holds a BS from Bucknell University and an MBA in Accounting from Pace University. Some of Bob's areas of coverage include Special Situations, Energy Industry, Property-Casualty Insurance and Banking. Bob is the principal of the managing member or general partner of several investment vehicles. Bob currently serves on the Board of Directors of Panhandle Oil & Gas Company, a NYSE-listed diversified mineral company located in Oklahoma City; as Chairman of the Board of Directors of Pulse Seismic Inc., a seismic data licensing business located in Calgary, Alberta; and on the Board of Directors of Build with BMC, a privately held company specializing in building materials and construction services throughout the United States. In addition, he serves on the Boards of many non-profit organizations where he generously donates his time and expertise. Previously, Bob was a member of the Securities and Exchange Commission's Advisory Committee on Smaller Public Companies, established to examine the impact of Sarbanes-Oxley Act and other aspects of the federal securities law.

“Singularity Universityssä ainoa kotitehtäväni kesän aikana oli kehittää ratkaisu, jolla voisin vaikuttaa myönteisesti miljardin ihmisen elämään”, kertoo maailman kiinnostavimpien tekoäly-yritysten joukkoon valitun Iris AI:n Maria Ritola yrityksensä alusta. The post Tekeekö robotti parempaa tiedettä kuin ihminen? appeared first on Sitra.

Tekoälyyn pohjautuva varainhoito on kuuma trendi maailmalla. Kutsuimme todellisen robo-advisor-asiantuntijan #rahapodin studioon. Evervestin Jussi Kallasvuo kertoo juurta jaksain, mitä robovarainhoito oikeasti tarkoittaa ja tuleeko se mullistamaan finanssialan. Mitä haittoja ja hyötyjä tekoälyn käyttämisessä sijoitustoiminnassa voi olla? Jakso julkaistu 2.2.2017

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bob Robotti, Founder and President of Robotti & Co., on risks and opportunities in MLPS and oil drilling stocks.

Tieteiskirjallisuuden kaikki kuvitelmat ovat oikeasti jo nurkan takana; auto ei enää tarvitse kuljettajaa, hoivarobotti jakaa lääkkeet ja verottajankin tylsimmät laskelmat tekee tekoäly. Kaikki kotona -ohjelmassa kylmältä ja kovalta tuntuvaan robotiikkaan haettiin tolkkua ja lämpöä paitsi kahden asiantuntijan, myös suloisen ja pörröisen vieraan avulla. Keskustelijoina olivat robottien etiikkaan perehtynyt kognitiotieteen tutkijatohtori Michael Laakasuo Helsingin yliopistosta ja Robotics Finland -hankkeen ja Robottiviikon puuhanainen, tietokirjailija Cristina Andersson. Ja se suloinen ja pörröinen vieras oli Paro -hyljerobotti, joka keskustelun lomassa äännähteli hylkeenpoikasen tavoin. Robotti-imurit ja ruohonleikkurit, leikkausrobotit, teollisuuden robotit, autot, Helsingin metro, tässä esimerkkejä missä kaikkialla meillä jo robotit tekevät työtä. Mihin niitä on tulossa lisää? Robotteja tulee lisää ihan joka sektorille, vakuuttaa Cristina Andersson. - Ei ole olemassa mitään elämän- tai elinkeinon aluetta, minne niitä ei olisi tulossa. Siksi juuri nyt pitää olla hereillä. On jopa uumoiltu, että vuonna 2020 Yhdysvaltain presidentti voisi olla robotti, niiden älykkyys kehittyy todella vauhdilla. Tällä hetkellä lovotics eli rakkausrobotiikka on isosti kehittyvä ala. Michael Laakasuon mukaan nopeasta kehityksestä kertoo sekin, että kun vuonna 2013 yritti puhua liikennerikkomuksia valvovista robottipoliiseista, aihetta pidettiin täytenä tieteisfiktiona. - Nykyään robottipoliisit ovat jo täyttä totta. Poliisin tehtäviä ulkoistetaan koneille Yhdysvalloissa, jossa A2d2:n näköisiä "peltipurkkirobotteja" toimii kaduilla esim. liikenteen valvontatehtävissä. Kuka kertoo robotille, mikä on oikein ja mikä väärin? Kuinka pahasti olemme myöhässä etiikan suhteen? Etiikan suhteen olemme auttamattomasti 20 vuotta myöhässä, pamauttaa Michael Laakasuo. - Meillä kysymykset siitä, mitä haluaisimme teknologialla tehdä, nousevat pintaan vasta, kun teknologia on jo luotu - eikä silloin kun nähdään, että tälläista teknologiaa voidaan luoda. Emme ole kaukaa viisaita. Cristina Andersson muistuttaa, että hoitoa tarvitsevien määrä kasvaa koko ajan. Robotisaatio tulee hoitotyöhön ihmiskäsille avuksi. - Meidän täytyy oppia suhteuttamaan hoitotyöhön liittyviä asioita. Inhimillistä hoitopanosta sinne, missä sitä eniten tarvitaan. - Tarvitsemme yhteiskuntatason strategioita, joissa myös eettiset näkökulmat on huomioitu. Pitää pystyä linjaamaan, miten saamme robotisaation etenemään maassa, joka on jäänyt kansainvälisestä kehityksestä jälkeen. Michael Laakasuo peräänkuuluttaa robottilakia. - Robottilaki voisi aluksi olla vain yksi lause, eräänlainen symbolinen avaus, tervetulotoivotus robotiikka-alan yrityksille. Se olisi selkeä viesti siitä, että Suomen hallinto tietäisi, että olemme liikkumassa kohti tulevaa ja olemme valmiita reagoimaan. - Poliittiset puolueet voisivat vääntää omien arvojensa mukaiseksi sen, millaisia robottilain yksityiskohdat olisivat. Todennäköisesti lakia päivitettäisiin sitä mukaa kun roboteille kehitetään uusia ominaisuuksia. Lähetystä luotsasi Paula Jokimies.